We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.015 | 1.09489051095 | 1.37 | 1.8 | 1.2499 | 20479 | 1.53888723 | CS |
4 | -0.325 | -19.0058479532 | 1.71 | 1.8 | 1.1535 | 10146 | 1.55958095 | CS |
12 | 0.564999 | 68.9022330461 | 0.820001 | 1.87 | 0.820001 | 12291 | 1.32847534 | CS |
26 | 0.6345 | 84.543637575 | 0.7505 | 1.87 | 0.6797 | 9076 | 1.15691025 | CS |
52 | -0.475 | -25.5376344086 | 1.86 | 2.32 | 0.6797 | 9006 | 1.29080096 | CS |
156 | -9.615 | -87.4090909091 | 11 | 19.56 | 0.6797 | 444613 | 11.26541702 | CS |
260 | -9.615 | -87.4090909091 | 11 | 19.56 | 0.6797 | 444613 | 11.26541702 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions